Lexicon Pharmaceuticals Inc Lxrx Ceo Lonnel Coats On Q2 2018 Results Earnings Call Transcript | Latest News RSS feed

Lexicon Pharmaceuticals Inc Lxrx Ceo Lonnel Coats On Q2 2018 Results Earnings Call Transcript - Latest News


Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q4 2018 Results - Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2018 Earnings Conference Call March 13, 2019 8:00 AM ET Company Participants Kimberly Lee - Head, Investor Relations and Corporate Strategy Lonnel Coats ... read more

Lexicon Pharmaceuticals Inc (LXRX) President and CEO Lonnel Coats Bought $376,200 of Shares

President and CEO of Lexicon Pharmaceuticals Inc (LXRX) Lonnel Coats bought 30,000 shares of LXRX on 09/15/2017 at an average price of $12.54 a share. The total cost of this purchase was $376,200. ... read more

Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update

THE WOODLANDS, Texas, July 30, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business ... good financial discipline,” said ... read more

Looking for another news?


Lexicon Pharmaceuticals, Inc. (LXRX)

complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your ... read more


Should You Worry About Lexicon Pharmaceuticals Inc’s (NASDAQ:LXRX) CEO Pay Cheque?

Lonnel Coats has been the CEO of Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) since 2014. This report will ... Lexicon Pharmaceuticals Inc has reduced its earnings per share by an average of 43% a year, ... read more

Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q2 2018 Results - Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2018 Earnings Conference Call July 30, 2018 8:00 AM ET Executives Kimberly Lee - IR Lonnel Coats - President and CEO Praveen Tyle - EVP, Research and ... read more

Lexicon Pharmaceuticals, Inc. (LXRX)

complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us